Tomomi Sanomachi

发表

Inhibition of the Lipid Droplet–Peroxisome Proliferator-Activated Receptor α Axis Suppresses Cancer Stem Cell Properties

M. Okada, C. Kitanaka, Kenta Kuramoto, 2021, Genes.

AS602801, an Anticancer Stem Cell Candidate Drug, Reduces Survivin Expression and Sensitizes A2780 Ovarian Cancer Stem Cells to Carboplatin and Paclitaxel

M. Okada, C. Kitanaka, S. Seino, 2018, AntiCancer Research.

Involvement of GLUT1-mediated glucose transport and metabolism in gefitinib resistance of non-small-cell lung cancer cells

M. Okada, C. Kitanaka, S. Seino, 2018, Oncotarget.

A Small-molecule Kinase Inhibitor, CEP-1347, Inhibits Survivin Expression and Sensitizes Ovarian Cancer Stem Cells to Paclitaxel

H. Yamashita, M. Okada, C. Kitanaka, 2018, AntiCancer Research.

Licochalcone A specifically induces cell death in glioma stem cells via mitochondrial dysfunction

M. Okada, C. Kitanaka, T. Kayama, 2017, FEBS open bio.

Dexamethasone Sensitizes Cancer Stem Cells to Gemcitabine and 5-Fluorouracil by Increasing Reactive Oxygen Species Production through NRF2 Reduction

M. Okada, C. Kitanaka, T. Yoshioka, 2021, Life.

Rho-Associated Protein Kinase (ROCK) Inhibitors Inhibit Survivin Expression and Sensitize Pancreatic Cancer Stem Cells to Gemcitabine.

M. Okada, C. Kitanaka, S. Seino, 2016, Anticancer research.

Antitumor activity of gemcitabine against high-grade meningioma in vitro and in vivo.

M. Okada, C. Kitanaka, K. Arita, 2017, Oncotarget.

Verteporfin inhibits oxidative phosphorylation and induces cell death specifically in glioma stem cells

M. Okada, C. Kitanaka, S. Seino, 2019, The FEBS journal.

Brexpiprazole, a Serotonin-Dopamine Activity Modulator, Can Sensitize Glioma Stem Cells to Osimertinib, a Third-Generation EGFR-TKI, via Survivin Reduction

M. Okada, C. Kitanaka, S. Seino, 2019, Cancers.

Brexpiprazole Reduces Survivin and Reverses EGFR Tyrosine Kinase Inhibitor Resistance in Lung and Pancreatic Cancer

M. Okada, C. Kitanaka, S. Seino, 2019, AntiCancer Research.

Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs

M. Okada, C. Kitanaka, S. Seino, 2019, Cancers.

Roles for hENT1 and dCK in gemcitabine sensitivity and malignancy of meningioma

M. Okada, C. Kitanaka, Y. Sonoda, 2021, Neuro-oncology.

Olanzapine, an Atypical Antipsychotic, Inhibits Survivin Expression and Sensitizes Cancer Cells to Chemotherapeutic Agents.

M. Okada, C. Kitanaka, S. Seino, 2017, Anticancer research.

Therapeutic targeting of pancreatic cancer stem cells by dexamethasone modulation of the MKP-1–JNK axis

M. Okada, C. Kitanaka, S. Seino, 2020, The Journal of Biological Chemistry.

Gemcitabine radiosensitization primes irradiated malignant meningioma cells for senolytic elimination by navitoclax

M. Okada, C. Kitanaka, S. Seino, 2021, Neuro-oncology advances.

AS602801 Sensitizes Ovarian Cancer Stem Cells to Paclitaxel by Down-regulating MDR1

M. Okada, C. Kitanaka, S. Seino, 2019, AntiCancer Research.

Aripiprazole, an Antipsychotic and Partial Dopamine Agonist, Inhibits Cancer Stem Cells and Reverses Chemoresistance.

M. Okada, C. Kitanaka, S. Seino, 2016, Anticancer research.

Repositioning CEP-1347, a chemical agent originally developed for the treatment of Parkinson’s disease, as an anti-cancer stem cell drug

M. Okada, C. Kitanaka, S. Seino, 2017, Oncotarget.

Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer

Masayuki Yoshida, E. Noguchi, T. Shimoi, 2023, Frontiers in Oncology.

AS602801, an Anti-Cancer Stem Cell Drug Candidate, Suppresses Gap-junction Communication Between Lung Cancer Stem Cells and Astrocytes

M. Okada, C. Kitanaka, S. Seino, 2018, AntiCancer Research.

In vitro and in vivo anti-tumor effects of brexpiprazole, a newly-developed serotonin-dopamine activity modulator with an improved safety profile

M. Okada, C. Kitanaka, S. Seino, 2019, Oncotarget.

COVID arm that appeared in the contralateral upper extremity after mRNA-1273 booster inoculation

K. Yonemori, Tomomi Sanomachi, Hitomi Sumiyoshi Okuma, 2023, International Cancer Conference Journal.

Inhibition of Retinoblastoma Cell Growth by CEP1347 Through Activation of the P53 Pathway

H. Yamashita, M. Okada, C. Kitanaka, 2020, AntiCancer Research.

Doxazosin, a Classic Alpha 1-Adrenoceptor Antagonist, Overcomes Osimertinib Resistance in Cancer Cells via the Upregulation of Autophagy as Drug Repurposing

M. Okada, C. Kitanaka, S. Seino, 2020, Biomedicines.

Lurasidone Sensitizes Cancer Cells to Osimertinib by Inducing Autophagy and Reduction of Survivin

M. Okada, C. Kitanaka, S. Seino, 2021, AntiCancer Research.

Antitumor activity of gemcitabine against high-grade meningioma in vitro and in vivo

M. Okada, C. Kitanaka, K. Arita, 2017, Oncotarget.